Inverse correlation between p16INK4A expression and NF-κB activation in melanoma progression

被引:12
作者
Ghiorzo, P [1 ]
Mantelli, M
Gargiulo, S
Gramigni, C
Pastorino, L
Banelli, B
Villaggio, B
Coccia, MC
Sementa, AR
Garrè, C
Bianchi-Scarrà, G
机构
[1] Univ Genoa, Dept Oncol Biol & Genet, I-16132 Genoa, Italy
[2] Univ Turin, Dept Clin Physiopathol, Turin, Italy
[3] Natl Inst Canc Res, Genoa, Italy
[4] Univ Geneva, Dept Internal Med, Genoa, Italy
[5] San Martino Hosp, Dept Pathol, Genoa, Italy
[6] G Gaslini Inst Children, Dept Pathol, Genoa, Italy
关键词
CDKN2A/p16INK4A; NF-kappa B p65; melanoma progression; expression; immunohistochemistry;
D O I
10.1016/j.humpath.2004.02.017
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Expression of p161NK4A, the product of the melanoma susceptibility gene CDKN2A, has been shown to decrease in correlation with tumor progression. P16INK4A is a key regulator of cell-cycle function, and likely interacts with a variety of targets alongside cyclin-dependent kinases (CDKs). One such target is nuclear factor KB (NF-kappaB), a pleiotropic transcription factor that plays a crucial role in apoptosis, oncogenesis and cell cycle control. NF-kappaB p65 has been shown to be activated in melanoma cell lines but few studies decribe its expression in the tissue. In the present study we focused on synchronous expression of p16INK4A and NF-kappaB p65 and their functional activation in melanoma cell lines and biopsy tissue. Activation of NF-kappaB p65, as observed by electrophoretic mobility shift assay in cell lines, was correlated with expression and cellular localization of the active and inactive forms of its inhibitor, IkappaB-alpha. In melanocytic lesions, p16INK4A and NF-kappaB p65 expression were inversely correlated with levels of the nuclear component of NF-kappaB p65 increasing from nevi to primary melanomas and metastases. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1029 / 1037
页数:9
相关论文
共 34 条
[1]   A RAPID MICROPREPARATION TECHNIQUE FOR EXTRACTION OF DNA-BINDING PROTEINS FROM LIMITING NUMBERS OF MAMMALIAN-CELLS [J].
ANDREWS, NC ;
FALLER, DV .
NUCLEIC ACIDS RESEARCH, 1991, 19 (09) :2499-2499
[2]   IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops [J].
Barzegar, C ;
Meazza, R ;
Pereno, R ;
Pottin-Clemenceau, C ;
Scudeletti, M ;
Brouty-Boyé, D ;
Doucet, C ;
Taoufik, Y ;
Ritz, J ;
Musselli, C ;
Mishal, Z ;
Jasmin, C ;
Indiveri, F ;
Ferrini, S ;
Azzarone, B .
ONCOGENE, 1998, 16 (19) :2503-2512
[3]  
Becker TM, 2001, CLIN CANCER RES, V7, P3282
[4]   New insights into the role of nuclear factor-κB in cell growth regulation [J].
Chen, F ;
Castranova, V ;
Shi, XL .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (02) :387-397
[5]  
Dhawan P, 2002, CANCER RES, V62, P7335
[6]   eMelanoBase:: An online locus-specific variant database for familial melanoma [J].
Fung, DCY ;
Holland, EA ;
Becker, TM ;
Hayward, NK ;
Bressac-de Paillerets, B ;
Mann, GJ .
HUMAN MUTATION, 2003, 21 (01) :2-7
[7]   Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients [J].
Ghiorzo, P ;
Villaggio, B ;
Sementa, AR ;
Hansson, J ;
Platz, A ;
Nicoló, G ;
Spina, B ;
Canepa, M ;
Palmer, JM ;
Hayward, NK ;
Bianchi-Scarrà, G .
HUMAN PATHOLOGY, 2004, 35 (01) :25-33
[8]  
Gilmore TD, 1996, ONCOGENE, V13, P1367
[9]   The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01 [J].
Graves, PR ;
Yu, LJ ;
Schwarz, JK ;
Gales, J ;
Sausville, EA ;
O'Connor, PM ;
Piwnica-Worms, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) :5600-5605
[10]  
Guttridge DC, 1999, MOL CELL BIOL, V19, P5785